World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
21059
World Ranking
13815
National Ranking
528

Nicole Rotmensz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Nicole Rotmensz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 287 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Nicole Rotmensz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Nicole Rotmensz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Nicole Rotmensz is affiliated with the European Institute of Oncology in Italy. Their research primarily focuses on Medicine, with significant contributions in subfields including Radiology, Nuclear Medicine and Imaging, Cancer Research, Pathology and Forensic Medicine, Artificial Intelligence, and Pulmonary and Respiratory Medicine.

The main topics of Nicole Rotmensz's work encompass:

  • Breast Cancer Treatment Studies
  • Medical Imaging Techniques and Applications
  • Radiomics and Machine Learning in Medical Imaging
  • Breast Lesions and Carcinomas
  • AI in cancer detection
  • Artificial Intelligence in Healthcare and Education
  • Reconstructive Surgery and Microvascular Techniques

Nicole Rotmensz's recent publications include:

  • Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes, 2023, JAMA Oncology
  • Evaluating the ability of an artificial-intelligence cloud-based platform designed to provide information prior to locoregional therapy for breast cancer in improving patient's satisfaction with therapy: The CINDERELLA trial, 2023, PLoS ONE
  • PET/MRI for Staging the Axilla in Breast Cancer: Current Evidence and the Rationale for SNB vs. PET/MRI Trials, 2021, Cancers
  • Abstract PO5-19-02: I-PREPARE: International Prospective REgistry on Pre-pectorAl breast Reconstruction (EUBREAST 11R-NCT 05817175), 2024, Cancer Research
  • Tailoring treatment of luminal A and lobular breast cancer with 18F FES-PET/MRI: FESTA trial, 2024, European Journal of Surgical Oncology

Frequent coauthors in Nicole Rotmensz's research include:

  • Oreste Gentilini
  • Rosa Di Micco
  • Giovanni Cisternino
  • Sara Baleri
  • Veronica Zuber

Publishing venues where Nicole Rotmensz has contributed multiple works include:

  • Cancer Research
  • European Journal of Surgical Oncology
  • European Journal of Cancer
  • JAMA Oncology
  • PLoS ONE

Best Publications

  • Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women

    U Veronesi;P Maisonneuve;A Costa;V Sacchini

  • Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial

    Umberto Veronesi;Roberto Orecchia;Roberto Orecchia;Patrick Maisonneuve;Giuseppe Viale;Giuseppe Viale

  • Very young women (<35 years) with operable breast cancer: features of disease at presentation

    M. Colleoni;N. Rotmensz;C. Robertson;L. Orlando

  • Does nipple preservation in mastectomy improve satisfaction with cosmetic results, psychological adjustment, body image and sexuality?

    F. Didier;D. Radice;S. Gandini;R. Bedolis

  • Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: A meta-analysis

    S. Iodice;M. Barile;N. Rotmensz;I. Feroce

  • Clinical Relevance of HER2 Overexpression/Amplification in Patients With Small Tumor Size and Node-Negative Breast Cancer

    Giuseppe Curigliano;Giuseppe Viale;Vincenzo Bagnardi;Luca Fumagalli

  • Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial

    Roberto Biffi;F. Orsi;S. Pozzi;U. Pace

  • Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer

    G. Cancello;P. Maisonneuve;N. Rotmensz;G. Viale;G. Viale

  • Tamoxifen for the Prevention of Breast Cancer: Late Results of the Italian Randomized Tamoxifen Prevention Trial Among Women With Hysterectomy

    Umberto Veronesi;Patrick Maisonneuve;Nicole Rotmensz;Bernardo Bonanni

  • Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination

    Caroline P. Le;Cameron J. Nowell;Corina Kim-Fuchs;Edoardo Botteri

  • Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons

    Umberto Veronesi;Roberto Orecchia;Roberto Orecchia;Alberto Luini;Alberto Luini;Viviana Galimberti

  • Prognostic Impact of Pregnancy After Breast Cancer According to Estrogen Receptor Status: A Multicenter Retrospective Study

    Hatem A. Azim;Niels Kroman;Marianne Paesmans;Shari Gelber

  • Locoregional recurrence risk after lipofilling in breast cancer patients

    J.Y. Petit;E. Botteri;V. Lohsiriwat;M. Rietjens

  • Breast carcinoma in elderly women: Features of disease presentation, choice of local and systemic treatments compared with younger postmenopausal patients

    Roberto Gennari;Giuseppe Curigliano;Nicole Rotmensz;Chris Robertson

  • A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients.

    Roberto Biffi;Filippo De Braud;Franco Orsi;Simonetta Pozzi

  • Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial

    Savino Bruno;Patrick Maisonneuve;Paola Castellana;Nicole Rotmensz

  • Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity.

    Giuseppe Viale;Nicole Rotmensz;Patrick Maisonneuve;Luca Bottiglieri

  • Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection.

    Umberto Veronesi;Viviana Galimberti;Luigi Mariani;Giovanna Gatti

  • Evaluation of fat grafting safety in patients with intra epithelial neoplasia: a matched-cohort study

    J.Y. Petit;M. Rietjens;E. Botteri;N. Rotmensz

  • A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases.

    Umberto Veronesi;C. De Cicco;V. E. Galimberti;J. R. Fernandez

Frequent Co-Authors

Giuseppe Viale
Giuseppe Viale University of Milan
Paolo Veronesi
Paolo Veronesi European Institute of Oncology
Vincenzo Bagnardi
Vincenzo Bagnardi University of Milano-Bicocca
Viviana Galimberti
Viviana Galimberti European Institute of Oncology
Patrick Maisonneuve
Patrick Maisonneuve European Institute of Oncology
Umberto Veronesi
Umberto Veronesi European Institute of Oncology
Marco Colleoni
Marco Colleoni European Institute of Oncology
Giancarlo Pruneri
Giancarlo Pruneri University of Milan
Aron Goldhirsch
Aron Goldhirsch European Institute of Oncology
Roberto Orecchia
Roberto Orecchia European Institute of Oncology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers in the USA doesn’t always mean attending traditional, on-campus programs. Many choose nursing as an entry point or alternative to medicine, taking advantage of flexible online routes. For those who already hold a nursing license, several rn to bsn cheapest programs are available online, providing a cost-effective way to further credentials and open new opportunities.

If you aspire to advanced practice or leadership, you might consider online phd nursing programs, which let you achieve a terminal degree from the flexibility of your home. Non-nurses looking to rapidly enter the field can explore direct entry msn programs for non nurses online, designed to fast-track students into advanced roles without a prior nursing background.

Entry requirements vary, so it's useful to know what is the easiest nursing school to get into when mapping out your education or career change. Online pathways offer accessibility, affordability, and rapid advancement, making them excellent options for future healthcare professionals.

Best Scientists Citing Nicole Rotmensz

Trending Scientists

Recently Published Articles